This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Name of User Fee | Fee Type | Fee-setting Authority | Reason for Planned Introduction of or Amendment to Fee | Effective Date of Planned Change | Consultation and Review Process Planned |
---|---|---|---|---|---|
Authority to Sell Drugs Fees - Amended | Regulatory Service (R) | Financial Administration Act (FAA) |
Fees are being amended because:
|
2008-09 | Building on consultations, the Independent Advisory Panels and the Parliamentary Review of the Fee Proposals conducted in 2007-08, publication of proposed fees is planned in Canada Gazette in 2008-09. |
Certificates of Pharmaceutical Product (Drug Export) Fees - Amended | Other Goods and Services (O) | Ministerial authority to enter into contract | |||
Drug Establishment Licensing Fees - Amended | R | FAA | |||
Drug Master File Fees - Amended | O | Ministerial authority to enter into contract | |||
Drug Submission Evaluation Fees - Amended | R | FAA | |||
Medical Device Licence Application Fees - Amended | R | FAA | |||
Fees for Right to Sell a Licensed Medical Device - Amended | R | FAA | |||
Medical Device Establishment Licensing Fees - Amended | R | FAA | |||
Veterinary Drug Evaluation Fees - Amended | R | FAA |
Fees are being reviewed because:
|
2010 | Fees related to veterinary drug product activities will be undergoing revision, and existing service standards may also be revisited, but no specific proposals or time lines are yet targeted for stakeholders. Consultations with stakeholders will take place prior to implementation. |
Natural Health Product Site Licensing Fee - New | R | FAA | Currently charging fees for similar activities for other product lines; will support program delivery; provides direct benefit to licence holder. | 2008-09 | Building on consultations conducted in late 2007-08, an official fee proposal will be published in early 2008-09, and Independent Advisory Panels will be arranged as required before presenting the proposal to Parliament. |
Active Pharmaceutical Ingredient Establishment Licensing Fees - New | R | FAA | |||
Good Clinical Practice Clinical Trial Site Registration Fee - New | R | FAA |
Additional information is available on the Health Products and Food Branch Cost Recovery Initiative website (http://www.hc-sc.gc.ca/dhp-mps/finance/costs-couts/index_e.html)